Hemodynamic changes determine the efficacy of thrombolysis: Results from an in-vitro flow model

Coronary Artery Disease

Volumn 9, Issue 1, 1998, Pages 43-48

  Kornowski, Ran ^a   Mendelevich, Lev ^a   Zaretsky, Uri ^b   Einav, Shmuel ^b   Laniado, Shlomo ^a   Keren, Gad ^a  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Blood pressure; Thrombolysis; Thrombus

Indexed keywords

STREPTOKINASE;

ARTICLE; BLOOD CLOT; BLOOD CLOT LYSIS; CONTROLLED STUDY; HEMODYNAMICS; HUMAN; HUMAN CELL; MODEL; NORMAL HUMAN; PERFUSION PRESSURE; PRIORITY JOURNAL; RECANALIZATION;

EID: 0031916296     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-199809010-00007     Document Type: Article

References (13)

1. Topol EJ. Thrombolytic interventions. In: Topol EJ (editor). Textbook of interventional cardiology. Philadelphia: WB Saunders; 1994. pp. 68-120.
2. Gruppo Italiano per lo Studio della Streptochinasi nell' Infarto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986; 1:397-402.
3. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomized trial of intravenous streptokinase, oral aspirin, both or neither among 17,189 cases of suspected acute myocardial infarction. Lancet 1988; 2:249-260.
4. Becker RC. Hemodynamic, mechanical, and metabolic determinants of thrombolytic efficacy: a theoretic framework for assessing the limitations of thrombolysis in patients with cardiogenic shock. Am Heart J 1993; 125:919-929.
5. Bates ER, Topol EJ. Limitations of thrombolytic therapy for acute myocardial infarction complicated by congestive heart failure and cardiogenic shock. J Am Coll Cardiol 1991; 18:1077-1084.
6. Prewitt RM, Gu S, Garber PJ, Ducas J. Marked systemic hypotension depresses coronary thrombolysis induced by intracoronary administration of recombinant tissue-type plasminogen activator. J Am Coll Cardiol 1992; 20:1626-1633.
7. Gurbel PA, Anderson RD, MacCord CS, Scott H, Komjathy SF, Poulton J, et al. Arterial diastolic pressure augmentation by intra-aortic balloon counterpulsation enhances the onset of coronary artery reperfusion by thrombolytic therapy. Circulation 1994; 89:361-365.
8. Prewitt RM, Gu S, Schick U, Ducas J. Intraaortic balloon counterpulsation enhances coronary thrombolysis induced by intravenous administration of a thrombolytic agent. J Am Coll Cardiol 1994; 23:297-298.
9. Sabol BM, Luippold RS, Hebert J, Ball SP, Corrao JM, Becker RC. Association between serial measures of systemic blood pressure and early coronary arterial perfusion status following intravenous thrombolytic therapy. J Thromb Thrombol 1994; 1:79-84.
10. Harpaz D, Chen X, Francis CW, Marder VJ, Meltzer RS. Ultrasound enhancement of thrombolysis and reperfusion in vitro. J Am Coll Cardiol 1993; 21:1507-1511.
11. Kono T, Morita H, Nishina T, Fujita M, Onaka H, Hirota Y, et al. Aortic counterpulsation may improve late patency of occluded coronary artery in patients with early failure of thrombolytic therapy. J Am Coll Cardiol 1996; 28:876-881.
12. Blinc A, Kennedy D, Bryant RG, Marder VJ, Francis CW. Flow through clots determines the rate and pattern of fibrinolysis. Thromb Haemost 1994; 71:230-235.
13. The GUSTO Angiographic Investigators. The effect of tissue plasminogen activator, streptokinase, or both on coronary artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med 1993; 329:1615-1622.